Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the cGAS-STING Pathway Inhibits Peripheral T-cell Lymphoma Progression and Enhances the Chemotherapeutic Efficacy.
Adv Sci (Weinh). 2024 Mar;11(10):e2306092. doi: 10.1002/advs.202306092. Epub 2023 Dec 25.
Adv Sci (Weinh). 2024.
PMID: 38145335
Free PMC article.
The cGAS-STING pathway is oncogenic in PTCL, whereas targeting cGAS suppresses tumor growth, and CLK1 may be a sensitivity indicator for cGAS inhibitors. These findings provide a theoretical foundation for optimizing therapeutic strategies for PTCL, especially in patients …
The cGAS-STING pathway is oncogenic in PTCL, whereas targeting cGAS suppresses tumor growth, and CLK1 may be a sensitivity indicator for cGA …
Metronomic chemotherapy for indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.
Liu H, Cao L, Zhao X, Miao Y, Wu W, Shi X, Zhang X, Yin H, Zhu H, Xu W, Li J, Fan L.
Liu H, et al.
Cancer Sci. 2023 Sep;114(9):3793-3796. doi: 10.1111/cas.15880. Epub 2023 Jun 20.
Cancer Sci. 2023.
PMID: 37340510
Free PMC article.
Item in Clipboard
Cite
Cite